Literature DB >> 17140660

Mutation analysis of CUTL1 in childhood myeloid neoplasias with monosomy 7.

Simone Hindersin, Charlotte M Niemeyer, Ulrich Germing, Ulrich Göbel, Christian P Kratz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140660     DOI: 10.1016/j.leukres.2006.10.021

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  5 in total

1.  The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).

Authors:  Bartosz Wasag; Els Lierman; Peter Meeus; Jan Cools; Peter Vandenberghe
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

2.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

Review 3.  CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Authors:  Zubaidah M Ramdzan; Alain Nepveu
Journal:  Nat Rev Cancer       Date:  2014-09-05       Impact factor: 60.716

4.  RAS transformation requires CUX1-dependent repair of oxidative DNA damage.

Authors:  Zubaidah M Ramdzan; Charles Vadnais; Ranjana Pal; Guillaume Vandal; Chantal Cadieux; Lam Leduy; Sayeh Davoudi; Laura Hulea; Lu Yao; Anthony N Karnezis; Marilène Paquet; David Dankort; Alain Nepveu
Journal:  PLoS Biol       Date:  2014-03-11       Impact factor: 8.029

Review 5.  SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.

Authors:  Josef Davidsson; Andreas Puschmann; Ulf Tedgård; David Bryder; Lars Nilsson; Jörg Cammenga
Journal:  Leukemia       Date:  2018-02-25       Impact factor: 11.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.